Página 3 - Melhores Cancro do fígado estádio 4 médicos - TOP-87 médicos

Mais de 28 anos de especialização em cancros do fígado e do pâncreas – O Dr. Ben-haim está entre os principais cirurgiões de oncologia gastrointestinal de Israel no Sourasky Medical Center.

• Especialista em cirurgia de Whipple para casos complexos
• Concentrar-se exclusivamente em cancros gastrointestinais
• Realizar intervenções avançadas para a gestão do cancro

O Prof. Wolfgang Köstler especializa-se em terapias oncológicas alvo, focando-se em neoplasias mamárias e ginecológicas. Combina décadas de experiência clínica com investigação de vanguarda.

• Mais de 20 anos de experiência em oncologia médica
• Especialista em medicina oncológica personalizada e imunoterapia
• Consultor sénior na Wiener Privatklinik
• Professor Associado na Universidade de Medicina de Viena
• Investigação publicada sobre o desenvolvimento de biomarcadores e biologia tumoral

O Professor Associado Dr. Yusuf Acikgoz traz experiência oncológica internacional da Ohio State University para o Hospital Universitário Lokman Hekim de Ancara.

• Especialização em Oncologia Médica com ampla formação na Turquia e nos EUA
• Participação em ensaios clínicos de Fase III para tratamentos avançados de cancro
• Membro da American Society of Clinical Oncology (ASCO)
• Certificação em Boas Práticas Clínicas e investigação em seres humanos

O Professor Associado Tahsin Ozatli é especialista em cancro da mama, do pulmão e gastrointestinal no Hospital Universitário Istinye Liv.

• Mais de 15 anos de experiência em oncologia
• Especialista em Medicina Interna no Hospital Estadual de Malatya
• Serviu na Clínica de Oncologia de Ancara e no Hospital Regional de Formação de Erzurum
• Estudos de medicina na Universidade de Selcuk

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Chefe do Centro de Câncer Gastrointestinal do Hadassah Medical Center – supervisiona diretamente casos complexos de câncer de fígado. Sua carreira de 33 anos é inteiramente focada em oncologia e radioterapia.

• Certificado pelo conselho em oncologia médica e radioterapia
• Formado e com carreira desenvolvida no Hospital Universitário Hadassah, em Jerusalém
• Membro ativo do Comitê Nacional de Câncer Gastrointestinal
• Experiência nas mais recentes terapias sistémicas e radiação direcionada
• Papel como médico sénior envolvido na formação de outros oncologistas

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

A Professora Gul Alco é especialista em rádio-oncologia no Medipol Acibadem District Hospital, com mais de 20 anos de experiência na área.

• Professora no Departamento de Rádio-Oncologia da Universidade Medipol de Istambul
• Concluir a residência na Faculdade de Medicina da Universidade Kadir Has
• Professora associada e, posteriormente, professora na Universidade Demiroglu Bilim
• Trabalhar no Hospital Şişli Florence Nightingale e no Hospital Gayrettepe Florence Nightingale

Nail Paksoy traz uma vasta experiência do Instituto de Oncologia da Universidade de Istambul e agora atua como Professor Associado no Hospital Medipol Bahçelievler.

• Especializar-se no tratamento do cancro do fígado com foco em estádios avançados
• Ser certificado em Oncologia Médica pela ESMO
• Contribuir para oito ensaios clínicos internacionais em oncologia
• Publicar vários artigos de investigação sobre cancros metastáticos

Especializado em cirurgia laparoscópica avançada e oncológica – o Dr. Al traz uma vasta formação das principais instituições médicas turcas.

• Formado na Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Especialização em técnicas laparoscópicas bariátricas e de refluxo
• Mais de 30 anos de experiência cirúrgica

Especialista em cirurgia de câncer de fígado minimamente invasiva no Hospital Medical Park Goztepe, com foco na redução do tempo de recuperação do paciente.

• Autor de mais de 40 documentos médicos
• Membro do corpo docente da Faculdade de Medicina da Universidade de Bahçeşehir
• Membro do conceituado American College of Surgeons
• Também membro da Liver Transplantation Society
• Formado nas Universidades de Cukurova e Ege

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Mais de 30 anos em imunologia com foco em viroterapia – A Dra. Jaunalksne é especialista em tratamentos imunológicos de ponta para cancro do fígado na Pallas Clinic.

• Liderar o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Formar-se no Instituto Médico de Riga e realizar um internato em Medicina Interna
• Focar na viroterapia, uma abordagem inovadora no tratamento do cancro

Especializado em cirurgias oncológicas complexas, incluindo procedimentos de fígado, pâncreas e vias biliares nos Hospitais Büyük Anadolu.

• Especialista em cirurgia oncológica com foco em cancros gastrointestinais
• Realizar cirurgias bariatras e metabólicas avançadas
• Capacitado em operações de cancro da mama e da tiroide

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.